Factors Associated With Long COVID Symptoms in an Online Cohort Study

Top Cited Papers
Open Access
Abstract
Few prospective studies of Long COVID risk factors have been conducted. The purpose of this study was to determine whether sociodemographic factors, lifestyle, or medical history preceding COVID-19 or characteristics of acute SARS-CoV-2 infection are associated with Long COVID. The COVID-19 Citizen Science (CCS) study is an online cohort study that began enrolling March 26, 2020, with longitudinal assessment of symptoms before, during, and after SARS-CoV-2 infection. Adult participants who reported a positive SARS-CoV-2 test result prior to April 4, 2022, were surveyed for Long COVID symptoms. The primary outcome was at least 1 prevalent Long COVID symptom greater than 1 month after acute infection. Exposures of interest included age, sex, race/ethnicity, education, employment, socioeconomic status/financial insecurity, self-reported medical history, vaccination status, variant wave, number of acute symptoms, pre-COVID depression, anxiety, alcohol and drug use, sleep, and exercise. Of 13,305 participants who reported a SARS-CoV-2 positive test, 1480 (11.1%) responded. Respondents’ mean age was 53 and 1017 (69%) were female. 476 (32.2%) reported Long COVID symptoms at a median 360 days after infection. In multivariable models, number of acute symptoms (OR 1.30 per symptom, 95%CI 1.20-1.40), lower socioeconomic status/financial insecurity (OR 1.62, 95%CI 1.02-2.63), pre-infection depression (OR 1.08, 95%CI 1.01-1.16), and earlier variants (OR 0.37 for Omicron compared to ancestral strain, 95%CI 0.15-0.90) were associated with Long COVID symptoms. Variant wave, severity of acute infection, lower socioeconomic status and pre-existing depression are associated with Long COVID symptoms.
Funding Information
  • National Institutes of Health (NIH)/National Institute of Biomedical Imaging and Bioengineering (3U2CEB021881-05S1)
  • Patient-Centered Outcomes Research Institute (COVID-2020C2-10761)
  • Bill & Melinda Gates Foundation (INV-017206)
  • NIH/National Heart, Lung, and Blood Institute Grant (K12HL143961)
  • NIH/NIAIN (K23AI157875)